Sarcoma Clinical Trials
There are 13 registered clinical trials for Sarcoma in the TrialLens index.
Trials (13)
- A Phase I Trial to Assess the Effects of Food and Formulation on PK of KPT-330 in Patients With Sarcoma Phase 1 · Karyopharm Therapeutics Inc
- A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202) Phase 1/2 · GlaxoSmithKline
- Chemotherapy in Treating Patients With Sarcoma of the Uterus Phase 2 · Gynecologic Oncology Group
- Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer N/A · Children's Oncology Group
- Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery Phase 1 · Steven Waggoner, MD
- Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer Phase 2 · Memorial Sloan Kettering Cancer Center
- Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma Phase 2 · SWOG Cancer Research Network
- Metabolic Syndrome in Childhood Cancer Survivors N/A · University of Minnesota
- Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma N/A · Children's Oncology Group
- Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma Phase 1/2 · Memorial Sloan Kettering Cancer Center
- A Study of Eribulin With Gemcitabine in Patients With Advanced Liposarcoma or Leiomyosarcoma Phase 2 · Yonsei University
- Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma Phase 2 · Eastern Cooperative Oncology Group
- Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors Phase 1 · Children's Oncology Group
Related landscapes
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.